Research Studies and Clinical Trials

An ongoing, worldwide scientific research continues to support Macafem’s efficacy and safety in treating a wide array of menopause symptoms.

Researchers from Wuhan University of Science and Technology in China have found scientific evidence that Macafem’s active component has hormone-balancing properties, particularly of estrogen and progesterone, which marks Macafem an effective and safe alternative to hormone replacement therapy (HRT). This study was conducted in 2014 by Zhang Yongzhong and his research team and has been published in the peer-reviewed Indian Journal of Pharmacology.

A 2014 systematic review of more than 80 scientific studies concluded that Lepidium meyenii, Macafem’s main ingredient, is beneficial in relieving menopause symptoms, such as hot flashes, nights sweats, and mood swings among women undergoing the menopausal transition. This comprehensive analysis was led by Gustavo F. Gonzales, MD., who is a prominent scientist at the Peruvian University Cayetano Heredia in Peru and has authored more than 250 scientific publications.

A team of Australian scientists conducted a 12-week, double-blind clinical trial involving postmenopausal women suffering from sexual dysfunction and found that Macafem’s active component can increase libido and improve sexual function. It has also been shown to reduce the severity of anxiety and depression. These findings have been featured in the 2008 publication of Menopause, the official Journal of the North American Menopause Society.